Letters to the Editor
Vol. 67 No. 3 (2015)
https://doi.org/10.4081/reumatismo.2015.849

Myasthenia gravis due to hydroxychloroquine

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 14 November 2015
Published: 9 February 2016
4137
Views
2237
Downloads
Letter to the Editor.

Authors

O. Varan
ozkanvaran84@gmail.com
Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Türkiye.
H. Kucuk
Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Türkiye.
A. Tufan
Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Türkiye.
No abstract available

Downloads

Download data is not yet available.
O. Varan, Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara
Department of Internal medicine, Division of Rheumatology

How to Cite



1.
Myasthenia gravis due to hydroxychloroquine. Reumatismo [Internet]. 2016 Feb. 9 [cited 2026 Sep. 17];67(3):125. Available from: https://www.reumatismo.org/reuma/article/view/849

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.